Faeth Therapeutics FTH
NASDAQ FTH
$20.57 -0.22 (-1.06%)
At close: Oct 21, 2026 · 4:00 PM EDT

Faeth Therapeutics (FTH) Research & Development (2020 - 2021)

Updated

Faeth Therapeutics' Research & Development was $3.37 million in Q1 2021, up 53.3% from $2.2 million a year earlier.

Analysis

Faeth Therapeutics (FTH) Research & Development (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.82 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 3.65 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 2.34 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 9.74 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 2.85 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 4.05 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.87 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 1.76 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 2.81 Bn
10 Faeth Therapeutics 115.80 Mn -319.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 3.37 Mn
Mar 31, 2020 2.20 Mn
API Access

Faeth Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=FTH&period=max&api_key=YOUR_API_KEY